1Fick-Brosnahan GM, Belz MM, McFann KK, et al. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis, 2002,39:1127-1134.
2National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis, 2002, 37 Suppl 1:S182-S238.
3Sessa A, Ghiggeri GM, Turco AE. Autosomal dominant polyeystic kidney disease: clinical and genetic aspects.J Nephrol,1997, 10:295-310.
4Sharp C, Johnson A, Gabow P. Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol, 1998, 9:1908-1914.
5Nicolau C, Torre R, Bianchi L, et al. Abdominal sonographic study of autosomal dominant polycystic kidney disease. J Clin Ultrasound, 2000,28:277-282.
6曹海根.实用超声诊断学[M].北京:人民卫生出版社,1994.459.
7King BF,Reed JE,Bergstralh EJ,et al.Quantification and longitudinal trends of kidney,renal cyst,and renal parenchyma volumes in autosomal dominant polycystic kidney disease.J Am Soc Nephrol,2000,11:1505-1511
8Brkljacic B,Sabljar MM,Putarek K,et al.Renal vascular resistance in autosomal dominant polycystic kidney disease:evaluation with color Doppler ultrasound.Acta Radiol,1997,38:840-846
9Sinibaldi D,Malenas S,Mingarelli R,et al.Prenatal ultrasonographic findings of dominant polycystic kidney disease and postnatal renal evolution.Am J Med Gen,1996,65:337-341
7Leuenroth S J, Okuhara D, Shotwell JD, et al. Triptolide is a tradition- al Chinese medicine derived inhibitor of polyeystic kidney disease [ J]. Proc Natl Aead Sci USA, 2007, 104 ( 11 ) : 4389-4394.
